1202873-68-4 Usage
Description
3-(4-tert-butylphenyl)-1,4-dimethyl-1H-pyrazol-5-ol, also known as Typhonium Plus, is a pyrazole derivative with potential applications in pharmaceutical research and development. It possesses anti-inflammatory and anti-nociceptive properties, making it a promising candidate for the development of new drugs for the management of pain and inflammation.
Uses
Used in Pharmaceutical Research and Development:
3-(4-tert-butylphenyl)-1,4-dimethyl-1H-pyrazol-5-ol is used as a chemical compound for the development of new drugs targeting pain and inflammation. Its anti-inflammatory and anti-nociceptive properties make it a potential candidate for further study and therapeutic use.
Used in Pain Management:
3-(4-tert-butylphenyl)-1,4-dimethyl-1H-pyrazol-5-ol is used as a potential drug candidate for the management of pain, due to its anti-nociceptive properties.
Used in Inflammation Treatment:
3-(4-tert-butylphenyl)-1,4-dimethyl-1H-pyrazol-5-ol is used as a potential drug candidate for the treatment of inflammation, owing to its anti-inflammatory properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1202873-68-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,2,8,7 and 3 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1202873-68:
(9*1)+(8*2)+(7*0)+(6*2)+(5*8)+(4*7)+(3*3)+(2*6)+(1*8)=134
134 % 10 = 4
So 1202873-68-4 is a valid CAS Registry Number.
1202873-68-4Relevant articles and documents
PYRAZOLONE DERIVATIVES AS NITROXYL DONORS
-
Page/Page column 181; 187; 315, (2016/01/29)
The disclosed subject matter provides pyrazolone derivative compounds, pharmaceutical compositions comprising such compounds, kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.
